Clinical Trials in Kirkcaldy, United Kingdom

7 recruiting

Showing 19 of 9 trials

Recruiting
Phase 3

Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)

Plaque Psoriasis
Bristol-Myers Squibb3,040 enrolled357 locationsNCT07116967
Recruiting
Phase 3

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

Cardiovascular DiseasesHypertensionDiabetes Mellitus, Type 2
Boehringer Ingelheim11,800 enrolled1152 locationsNCT07064473
Recruiting

HDClarity: a Multi-site Cerebrospinal Fluid Collection Initiative to Facilitate Therapeutic Development for Huntington's Disease

Huntington’s Disease
University College, London2,500 enrolled40 locationsNCT02855476
Recruiting

Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults

Atopic Dermatitis
Galderma R&D1,000 enrolled108 locationsNCT06988605
Recruiting

A Retrospective Study to Characterize Participants With Propionic Acidemia

Propionic Acidemia
ModernaTX, Inc.60 enrolled29 locationsNCT05769621
Recruiting

MIDI (MR Imaging Abnormality Deep Learning Identification)

Neurological Disorder
King's College Hospital NHS Trust30,000 enrolled33 locationsNCT04368481
Recruiting
Phase 3

A Randomised Open-label Phase III Trial of REduced Frequency Pembrolizumab immuNothErapy for First-line Treatment of Patients With Advanced Non-small Cell Lung Cancer (NSCLC)

Lung Cancer, Nonsmall Cell
Imperial College London1,750 enrolled37 locationsNCT05085028
Recruiting

Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort

Huntington’s Disease
CHDI Foundation, Inc.35,000 enrolled183 locationsNCT01574053
Recruiting

Clinical and Functional Outcome of the MobileLink Acetabular Cup System in the Short-, Mid-, and Longterm Follow-up

Osteoarthritis, HipProsthesis Failurehip osteoarthritis+1 more
Waldemar Link GmbH & Co. KG520 enrolled2 locationsNCT04688593